D-shufo™ Occluder is a new generation of patent foramen ovale (PFO) occluder independently developed in China. It has been comprehensively optimized in both structure and material processing. The disc-like inward-folded design enhances the stability and conformity after implantation, significantly improving the success rate of treatment. In terms of material selection, the D-shufo™ Occluder is made of high-quality nickel-titanium alloy, coated with Parylene on the surface, effectively reducing the release of nickel ions and further enhancing the safety of the product. We believe that with the widespread application of this product, more patients will benefit.

The PFO industry has gone through more than 20 years of challenges and has now gradually moved towards technological maturity and stability. Behind this development is the close cooperation between clinicians and manufacturers, as well as the long-term safety and effectiveness demonstrated by nickel-titanium alloy occluders in clinical applications. The D-shufo™ PFO Occluder is the third domestically produced occluder approved in China for PFO-related indications, providing a new treatment device for cardioembolic stroke. It is expected that this product will bring new breakthroughs to the PFO industry and promote technological advancement and innovation in this field.

We are delighted to see new devices entering the market in the PFO field. The D-shufo™ occluder is made from braided nitinol wires, and its material has been clinically validated for 20 years, proving to be safe, reliable, and trustworthy. Additionally, the complex structure of patent foramen ovale places high demands on the adaptability and precision of occluders. The new generation of D-shufo™ occluders comes in 12 different specifications, fully considering the clinical needs of various patients to ensure that every patient receives the most suitable treatment option. We look forward to witnessing the outstanding performance of the D-shufo™ occluder in clinical applications.

In the field of cardiogenic stroke prevention, with the widespread adoption and application of PFO technology, the selection of indications has become crucial. Grasping the optimal indications is key to ensuring treatment effectiveness, thereby truly realizing the medical concept of "treating the heart and brain together" and benefiting more patients. The launch of the D-shufo™ occluder not only provides a new treatment option for cardiogenic stroke prevention but also injects new vitality into the long-term development of the PFO industry.

In recent years, the concept of "treating the heart and brain simultaneously" has gained increasing clinical attention, becoming a research hotspot in cardiovascular and cerebrovascular diseases. The era of interventional prevention for cardiogenic stroke has arrived. Among these, the significance of patent foramen ovale (PFO) closure technology in preventing strokes has been clinically validated. The launch of Vickor's D-shufo™ occluder will enhance the standardized use of the device. With the widespread application of the D-shufo™ occluder, PFO closure technology is expected to be more extensively utilized in clinical practice, becoming an important method for the interventional prevention of cardiogenic stroke.

Prevention and treatment of PFO-related stroke have been a research hotspot in the past decade. A large amount of evidence shows that PFO closure benefits stroke patients; however, regarding PFO-related non-stroke conditions such as migraines,Decompression SicknessThe evidence is relatively limited. We look forward to the D-shufo™ PFO Occluder providing more evidence-based medical proof in its future applications, making a significant contribution to the treatment of patent foramen ovale.

As a clinical researcher of the D-shufo™ PFO Occluder, I am very pleased to see the product's registration and market launch. With its excellent design, the D-shufo™ Occluder addresses many clinical pain points, reduces residual shunts, and optimizes endothelialization effects within the occluder. The D-shufo™ Occluder has a short learning curve for clinical application, is easy to operate, and highly safe, providing clinicians with an excellent interventional device for PFO closure and offering patients with indications a reliable solution.PFO PatientsBring Good News!